Remove 2009 Remove Patients Remove Vertebrae
article thumbnail

ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain

OrthoSpineNews

a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced it has treated the first patient in its HYDRAFIL-D FDA investigational device exemption (IDE) clinical trial for its HYDRAFIL ® System for disc augmentation. in Walnut Creek, Calif. Jasper, Ga.;

article thumbnail

Presentation at CFA Congress of Positive Results Obtained for SpineGuard’s New Ultrasound Technology

OrthoSpineNews

.” Quentin Grimal, Professor at Sorbonne University, member of LIB (CNRS 7371 – INSERM 1146) and co-author of the study, added: The results presented during this conference demonstrate that is possible to identify thanks to the ultrasounds, in realistic models of human vertebra, the optimal angle for a secured pedicle drilling.